Jun An Lu
Directeur/Membre du Conseil chez EpimAb Biotherapeutics, Inc.
Profil
Jun An Lu currently works at EpimAb Biotherapeutics, Inc., as Director.
Mr. Lu also formerly worked at Inmyshow Digital Technology (Group) Co., Ltd., as Securities Representative.
Postes actifs de Jun An Lu
| Sociétés | Poste | Début |
|---|---|---|
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jun An Lu
| Sociétés | Poste | Fin |
|---|---|---|
| INMYSHOW DIGITAL TECHNOLOGY(GROUP)CO.,LTD. | Investor Relations Contact | 26/01/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INMYSHOW DIGITAL TECHNOLOGY(GROUP)CO.,LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Health Technology |
